Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Return on Capital Employed (2016 - 2017)

Historic Return on Capital Employed for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q1 2017 value amounting to 2.75%.

  • Eledon Pharmaceuticals' Return on Capital Employed fell 19900.0% to 2.75% in Q1 2017 from the same period last year, while for Mar 2017 it was 2.75%, marking a year-over-year decrease of 19900.0%. This contributed to the annual value of 1.24% for FY2016, which is 6900.0% down from last year.
  • According to the latest figures from Q1 2017, Eledon Pharmaceuticals' Return on Capital Employed is 2.75%, which was down 19900.0% from 2.53% recorded in Q4 2016.
  • In the past 5 years, Eledon Pharmaceuticals' Return on Capital Employed ranged from a high of 0.23% in Q4 2014 and a low of 2.75% during Q1 2017
  • Moreover, its 4-year median value for Return on Capital Employed was 0.72% (2015), whereas its average is 1.06%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -4400bps in 2016, then crashed by -19900bps in 2017.
  • Over the past 4 years, Eledon Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.23% in 2014, then plummeted by -199bps to 0.68% in 2015, then crashed by -273bps to 2.53% in 2016, then decreased by -9bps to 2.75% in 2017.
  • Its last three reported values are 2.75% in Q1 2017, 2.53% for Q4 2016, and 1.28% during Q3 2016.